Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023


Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2023 will be released before the market opens on Thursday, May 11th.

Management will host a conference call at 8:00 a.m. Eastern Time on May 11th to discuss the results of the quarter, and to host a question and answer session. To listen to the call by phone, interested parties may dial 877-407-8289 (or 201-689-8341 for international callers) and provide access code 13737575. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company's website and at:

https://event.choruscall.com/mediaframe/webcast.html?webcastid=gfBZBEow

A telephonic replay will be available approximately two hours through the following two weeks. The replay can be accessed by dialing 877-660-6853 for U.S. callers or 201-612-7415 for international callers and using the replay access code: 13737575. The webcast will be archived on the Investor Relations section of the Company's website.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.


These press releases may also interest you

at 04:24
Beijing Review: Service For a Better World
"What do you want to be when you grow up?" "Us children in Palestine do not grow up." This snippet comes from a conversation between a reporter and a child in the war-torn Palestinian enclave that is the Gaza Strip in 2023. Even today, the agonies of...

at 03:27
SM focuses on expansion to serve more regions
The SM group continues to expand its presence nationwide to serve more Filipinos and communities. "We will continue to invest in growth in the Philippines and we are committed to being a catalyst for responsible development. We have a young,...

at 03:25
UnionPay Now Accepted on JD.com: Cross-Border Shopping Made Easier for Global Customers
UnionPay International (UPI) has teamed up with JD PAY, JD.com's digital payment service to elevate the cross-border shopping experience, enabling customers around the world to use their local UnionPay cards on JD.com. This partnership is a major...

at 03:25
Greater efforts urged on sci-tech cooperation
A news report from China Daily: Greater efforts are needed to strengthen international cooperation in science and technology, explore...

at 03:08
SCA: Interim report, Q1 2024
January?March 2024 compared with January?March 2023 Net sales declined to SEK 4,558m (4,813). The sales decrease was mainly due to lower selling prices. Delivery volumes increased compared with the preceding year due to a gradual ramp up of...

at 02:40
Pearson 2024 Q1 Trading Update (Unaudited)
Highlights Underlying sales growth excluding OPM1 and Strategic Review2 of 3%. Strong operational progress in all divisions and continued execution momentum across our 2024 strategic priorities. Continuing to infuse our products with AI and...

More news about Business...


News published on and distributed by: